Grant

Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses

Patent Number US-11883446-B2

Publication Year 2024

Granted Year: 2024

Application Year 2022

Priority Year 2020

Jurisdiction US

Status Active

Inventors

GUERY SEBASTIEN LEHTINEN MARKUS LATVALA SINIKKA ANNELI LEHTORANTA LIISA ZABEL BRYAN-JAMES MOROVIC WESLEY WILLIAM BUDINOFF CHARLES POWER SCOTT D

Applicants

  1. DuPont (Denmark)
  2. [NORA names: DuPont; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

This invention relates to bacterial strains, compositions comprising bacterial strains as well as methods and uses of said strains and compositions for preventing or treating illness and/or symptoms associated with a coronavirus in a subject in need thereof.

Patent Family Records (8)

Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2024, US-11883446-B2

PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES  

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2023, EP-4178597-A2

Probiotics for preventing or treating coronavirus-related diseases and/or symptoms  

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY STEPHANE, LEHTINEN MARKUS, RATHWALA SUJATHA ASHOK, (...more)

2023, CN-116018152-A

PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES  

DANISCO US INC, DUPONT NUTRITION BIOSCI APS, DuPont (Denmark), DuPont (United States) GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2022, WO-2022011271-A3

PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES  

DANISCO US INC, DUPONT NUTRITION BIOSCI APS, DuPont (Denmark), DuPont (United States) GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2022, WO-2022011271-A2

PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES  

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2022, US-20220370519-A1

PROBIOTICS FOR USE IN THE PREVENTION OR TREATMENT OF ILLNESS AND/OR SYMPTOMS ASSOCIATED WITH CORONAVIRUSES  

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2022, US-20220008488-A1

Probiotics for use in the prevention or treatment of illness and/or symptoms associated with coronaviruses  

DuPont (Denmark), DuPont Nutrition Biosciences ApS GUERY SEBASTIEN, LEHTINEN MARKUS, LATVALA SINIKKA ANNELI, (...more)

2022, US-11318174-B2

Data Provider: Digital Science